Replies to post #39920 on Avid Bioservices Inc (CDMO)

[entdoc]

honestabe:you are that:honest. I have given this subject some minutes this morning. Specifically, evaluating Nature Medicine and the value of publication in that magazine. Who wrought the fixation on that publication? Not anyone friendly toward scientific progress. The HIV rehash we've been waiting for includes (I'll list only two for fear of boredom): "Structural definition of a conserved neutralization epitope on HIV-1 gp120", and how about "Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells". It's a different world, and not a bavi new world. A different attack strategy. Important, but not PPHM or Duke. A different league. PPHM and Duke could put these guys out of business. Probably some of the posters here. Hey a love the board here but the scene is still cluttered by big pharma goons. Let's move the ball forward. PPHM has incredible momentum now. The "New Scientist" article says it all. Look at who is financing Nature. It isn't the guy on the street payin' a dime for that news. It is big Pharma tootin' it ancient horns. Let's stay focused and get the message through.

[geocappy1]

Agreed, however, you are wasting your breath on some of these people. Anybody worth anything could see that the evidence is building and showing up in various places little by little. For people to draw conclusions based on a Duke report not being published when the on ly ones who control the publication is the Journal itself is amazing.

I share your concern about protecting the ownership rights of the science.